Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Expression of Osteoblast-Specific Factor 2 (OSF-2, Periostin) Is Associated with Drug Resistance in Ovarian Cancer Cell Lines.

Sterzyńska K, Kaźmierczak D, Klejewski A, Świerczewska M, Wojtowicz K, Nowacka M, Brązert J, Nowicki M, Januchowski R.

Int J Mol Sci. 2019 Aug 13;20(16). pii: E3927. doi: 10.3390/ijms20163927.

3.

PTPRK Expression Is Downregulated in Drug Resistant Ovarian Cancer Cell Lines, and Especially in ALDH1A1 Positive CSCs-Like Populations.

Świerczewska M, Sterzyńska K, Wojtowicz K, Kaźmierczak D, Iżycki D, Nowicki M, Zabel M, Januchowski R.

Int J Mol Sci. 2019 Apr 25;20(8). pii: E2053. doi: 10.3390/ijms20082053.

4.

Mutual Expression of ALDH1A1, LOX, and Collagens in Ovarian Cancer Cell Lines as Combined CSCs- and ECM-Related Models of Drug Resistance Development.

Sterzyńska K, Klejewski A, Wojtowicz K, Świerczewska M, Nowacka M, Kaźmierczak D, Andrzejewska M, Rusek D, Brązert M, Brązert J, Nowicki M, Januchowski R.

Int J Mol Sci. 2018 Dec 23;20(1). pii: E54. doi: 10.3390/ijms20010054.

5.

Myotilin, a New Topotecan Resistant Protein in Ovarian Cancer Cell Lines.

Sterzyńska K, Klejewski A, Wojtowicz K, Świerczewska M, Nowicki M, Brązert J, Januchowski R.

J Cancer. 2018 Oct 22;9(23):4413-4421. doi: 10.7150/jca.27342. eCollection 2018.

6.

The Role of Matrix Gla Protein (MGP) Expression in Paclitaxel and Topotecan Resistant Ovarian Cancer Cell Lines.

Sterzyńska K, Klejewski A, Wojtowicz K, Świerczewska M, Andrzejewska M, Rusek D, Sobkowski M, Kędzia W, Brązert J, Nowicki M, Januchowski R.

Int J Mol Sci. 2018 Sep 25;19(10). pii: E2901. doi: 10.3390/ijms19102901.

7.

Tissue expression of β-catenin and E- and N-cadherins in chronic hepatitis C and hepatocellular carcinoma.

Kasprzak A, Rogacki K, Adamek A, Sterzyńska K, Przybyszewska W, Seraszek-Jaros A, Helak-Łapaj C, Pyda P.

Arch Med Sci. 2017 Oct;13(6):1269-1280. doi: 10.5114/aoms.2017.65272. Epub 2017 Jan 19.

8.

The significance of lumican expression in ovarian cancer drug-resistant cell lines.

Klejewski A, Sterzyńska K, Wojtowicz K, Świerczewska M, Partyka M, Brązert M, Nowicki M, Zabel M, Januchowski R.

Oncotarget. 2017 Aug 10;8(43):74466-74478. doi: 10.18632/oncotarget.20169. eCollection 2017 Sep 26.

9.

Microarray-based detection and expression analysis of new genes associated with drug resistance in ovarian cancer cell lines.

Januchowski R, Sterzyńska K, Zawierucha P, Ruciński M, Świerczewska M, Partyka M, Bednarek-Rajewska K, Brązert M, Nowicki M, Zabel M, Klejewski A.

Oncotarget. 2017 Jul 25;8(30):49944-49958. doi: 10.18632/oncotarget.18278.

10.

Atypical thymic carcinoid manifesting with nephrotic-range proteinuria in a 7-year-old boy.

Soltysiak J, Ostalska-Nowicka D, Zaorska K, Sterzyńska K, Derwich K, Zachwieja J.

Pediatr Nephrol. 2017 Aug;32(8):1465-1468. doi: 10.1007/s00467-017-3685-5. Epub 2017 May 5.

PMID:
28477260
11.

Analysis of MDR genes expression and cross-resistance in eight drug resistant ovarian cancer cell lines.

Januchowski R, Sterzyńska K, Zaorska K, Sosińska P, Klejewski A, Brązert M, Nowicki M, Zabel M.

J Ovarian Res. 2016 Oct 18;9(1):65.

12.

Increased Expression of Several Collagen Genes is Associated with Drug Resistance in Ovarian Cancer Cell Lines.

Januchowski R, Świerczewska M, Sterzyńska K, Wojtowicz K, Nowicki M, Zabel M.

J Cancer. 2016 Jun 25;7(10):1295-310. doi: 10.7150/jca.15371. eCollection 2016.

13.

Disturbances in apoptosis of lamina propria lymphocytes in Crohn's disease.

Eder P, Łykowska-Szuber L, Krela-Kaźmierczak I, Stawczyk-Eder K, Iwanik K, Majewski P, Sterzyńska K, Zabel M, Linke K.

Arch Med Sci. 2015 Dec 10;11(6):1279-85. doi: 10.5114/aoms.2015.54203. Epub 2015 Dec 11.

14.

Silane-modified surfaces in specific antibody-mediated cell recognition.

Sterzynska K, Budna J, Frydrych-Tomczak E, Hreczycho G, Malinska A, Maciejewski H, Zabel M.

Folia Histochem Cytobiol. 2014;52(3):250-5. doi: 10.5603/FHC.2014.0029.

15.

Anti-TNF antibodies do not induce the apoptosis of lamina propria mononuclear cells in uninflamed intestinal tissue in patients with Crohn's disease.

Eder P, Lykowska-Szuber L, Krela-Kazmierczak I, Stawczyk-Eder K, Sterzynska K, Iwanik K, Majewski P, Zabel M, Linke K.

Folia Histochem Cytobiol. 2013;51(3):239-43. doi: 10.5603/FHC.2013.0034.

16.

The insulin-like growth factor-1 and expression of its binding protein‑3 in chronic hepatitis C and hepatocellular carcinoma.

Adamek A, Kasprzak A, Mikoś H, Przybyszewska W, Seraszek-Jaros A, Czajka A, Sterzyńska K, Mozer-Lisewska I.

Oncol Rep. 2013 Sep;30(3):1337-45. doi: 10.3892/or.2013.2546. Epub 2013 Jun 19.

PMID:
23784592
17.

Analysis of the specificity and selectivity of anti-EpCAM antibodies in breast cancer cell lines.

Sterzynska K, Kempisty B, Zawierucha P, Zabel M.

Folia Histochem Cytobiol. 2012;50(4):534-41. doi: 10.5603/17845.

18.

Expression of ghrelin receptor (GHSR-1a) in rat epididymal spermatozoa and the effects of its activation.

Łukaszyk A, Kotwicka M, Jankowska A, Kasprzak A, Ruciński M, Sterzyńska K, Ziółkowska A, Sawiński P, Ruchala M.

Reprod Biol. 2012 Nov;12(3):293-300. doi: 10.1016/j.repbio.2012.09.002. Epub 2012 Oct 17.

PMID:
23153700
19.

A novel method for the in vivo isolation of circulating tumor cells from peripheral blood of cancer patients using a functionalized and structured medical wire.

Saucedo-Zeni N, Mewes S, Niestroj R, Gasiorowski L, Murawa D, Nowaczyk P, Tomasi T, Weber E, Dworacki G, Morgenthaler NG, Jansen H, Propping C, Sterzynska K, Dyszkiewicz W, Zabel M, Kiechle M, Reuning U, Schmitt M, Lücke K.

Int J Oncol. 2012 Oct;41(4):1241-50. doi: 10.3892/ijo.2012.1557. Epub 2012 Jul 16.

20.

Histological alterations of gallbladder mucosa and selected clinical data in young patients with symptomatic gallstones.

Kasprzak A, Malkowski W, Biczysko W, Seraszek A, Sterzyńska K, Zabel M.

Pol J Pathol. 2011;62(1):41-9.

Supplemental Content

Loading ...
Support Center